Ryvu Therapeutics SA Free Cash Flow Generation Index

Latest as of December 2022: 0.93x

Ryvu Therapeutics SA free cash flow generation index. Ryvu Therapeutics SA (RVU) has a Free Cash Flow Generation Index of 0.93x as of December 2022. Free cash flow of zł55.70 Million represents 1% of operating cash flow (zł59.92 Million).

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

zł55.70 Million
PLN

Operating Cash Flow

zł59.92 Million
PLN

Capital Expenditures

zł4.22 Million
PLN

Free Cash Flow Generation Index of Ryvu Therapeutics SA (2017–2022)

Free cash flow generation index of Ryvu Therapeutics SA from 2017 to 2022. Historical FCF Generation Index trend for Ryvu Therapeutics SA across 2 annual periods. See RVU FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Ryvu Therapeutics SA Free Cash Flow Generation Index by Year (2017–2022)

Ryvu Therapeutics SA free cash flow generation index by year from 2017 to 2022. Year-by-year Free Cash Flow Generation Index for Ryvu Therapeutics SA. For the full cash flow conversion analysis, see RVU cash generation efficiency.

Year FCG Index Free Cash Flow (PLN) Operating CF Capital Expenditures YoY Change
2022 0.56x zł12.03 Million zł21.32 Million zł9.29 Million ▲ +158.6%
2017 -0.96x zł-10.58 Million zł10.98 Million zł21.56 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).